C9ORF102 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.53350004600861E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.1497999996557E-08 |
Normal-vs-Stage2 |
4.30089999999828E-05 |
Normal-vs-Stage3 |
2.4752999999933E-05 |
Normal-vs-Stage4 |
8.4865000000045E-05 |
Stage1-vs-Stage2 |
9.940400E-01 |
Stage1-vs-Stage3 |
8.416800E-01 |
Stage1-vs-Stage4 |
6.824800E-01 |
Stage2-vs-Stage3 |
8.705200E-01 |
Stage2-vs-Stage4 |
6.657400E-01 |
Stage3-vs-Stage4 |
5.613000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.54079999870049E-08 |
Normal-vs-AfricanAmerican |
9.08899999707558E-09 |
Normal-vs-Asian |
7.74589947738491E-10 |
Caucasian-vs-AfricanAmerican |
3.722800E-01 |
Caucasian-vs-Asian |
1.235170E-03 |
AfricanAmerican-vs-Asian |
1.255990E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.32719946144277E-10 |
Normal-vs-Female |
3.958200E-03 |
Male-vs-Female |
1.782250E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.07780000005542E-06 |
Normal-vs-Extreme_Weight |
9.70580005255073E-09 |
Normal-vs-Obese |
5.98909999999231E-05 |
Normal-vs-Extreme_Obese |
2.21799999999828E-05 |
Normal_Weight-vs-Extreme_Weight |
5.756600E-01 |
Normal_Weight-vs-Obese |
3.347000E-01 |
Normal_Weight-vs-Extreme_Obese |
6.384000E-01 |
Extreme_Weight-vs-Obese |
9.506100E-02 |
Extreme_Weight-vs-Extreme_Obese |
8.682200E-01 |
Obese-vs-Extreme_Obese |
2.550600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.200600E-04 |
Normal-vs-Age(41-60Yrs) |
1.69964999999772E-05 |
Normal-vs-Age(61-80Yrs) |
2.36380026663596E-10 |
Normal-vs-Age(81-100Yrs) |
8.19159999831953E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.341200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.196200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.457590E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.231920E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.495000E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.612590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
8.40730041140603E-10 |
Normal-VS-Type2 PRCC |
1.35119999966626E-07 |
Normal-VS-KIRP CIMP |
2.742300E-02 |
Normal-VS-Unclassified PRCC |
9.798900E-04 |
Type1 PRCC-VS-Type2 PRCC |
6.029000E-01 |
Type1 PRCC-VS-KIRP CIMP |
1.936190E-01 |
Type1 PRCC-VS-Unclassified PRCC |
7.843800E-02 |
Type2 PRCC-VS-KIRP CIMP |
2.706600E-01 |
Type2 PRCC-VS-Unclassified PRCC |
1.963210E-01 |
KIRP CIMP-VS-Unclassified PRCC |
8.143800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.63710197912337E-11 |
Normal-vs-N1 |
1.619290E-04 |
Normal-vs-N2 |
4.001200E-03 |
N0-vs-N1 |
1.069400E-01 |
N0-vs-N2 |
9.135400E-01 |
N1-vs-N2 |
5.713600E-01 |
|
|